Episode #38: Radhika Govindrajan
Play • 49 min
Cruising towards the end of 2020, we are back with a new conversation between Matt, Tim and Radhika Govindrajan about relatedness, lives with other species, and the changing context for doing ethnography today. Dr Gonvindrajan is Associate Professor of Anthropology at the University of Washington whose research spans the fields of multispecies ethnography, environmental anthropology, the anthropology of religion, South Asian Studies, and political anthropology. Their outstanding first book 'Animal Intimacies' (University of Chicago Press, 2018) is an ethnography of relatedness in the Central Himalayan state of Uttarakhand in India, and the book has since been was awarded the 2017 American Institute of Indian Studies Edward Cameron Dimock Prize in the Indian Humanities and the Society for Cultural Anthropology's Gregory Bateson Prize in 2019.

--
Conversations in Anthropology is a podcast about life, the universe, and anthropology produced by David Boarder Giles, Timothy Neale, Cameo Dalley, Mythily Meher and Matt Barlow. This podcast is made in partnership with the American Anthropological Association and supported by the Faculty of Arts & Education at Deakin University. Find us at conversationsinanthropology.wordpress.com or on Twitter at @AnthroConvo
DNA Today: A Genetics Podcast
DNA Today: A Genetics Podcast
Kira Dineen
#141 Stan Crooke on Ultra Rare Disease Drugs
Biotech titan Dr. Stan Crooke joins host Kira Dineen to celebrate rare disease month! Dr. Crooke was the Founder of IONIS Pharmaceuticals, with extensive experience in the pharmaceutical industry developing more than 20 marketed drugs. He has published nearly 500 scientific publications, edited more than 20 books, and has numerous patents.  Dr. Stan Crooke is now the Founder and CEO of n-Lorem Foundation, a new San Diego-based organization with an incredible mission of developing individualized RNA targeted medicines for patients with ultra-rare diseases, and providing those treatments for free, for life. These patients have extremely unique mutations and are often only one of 30 people in the entire world to have the disease. After only one year as a foundation, they’ve already made great progress for the ultra rare community, having received 50 applications from patients with ultra rare genetic mutations. Out of those 50, they have greenlighted treatment plans for nearly 20 patients - greatly exceeding application and acceptance rate expectations.  On This Episode We Discuss: Rare diseases vs ultra rare diseases Challenges treating patients with ultra rare diseases and genetic mutations Standard process and cost of drug development n-Lorem’s new approach to drug development for ultra rare diseases  Antisense therapies (ASOs) n-Lorem’s charitable and scalable model  n-Lorem’s relationship with IONIS Pharmaceuticals People eligible for n-Lorem’s treatments How to contact n-Lorem’s for potential treatment  Drugs currently in development at n-Lorem Insight on the development of SPINRAZA® for spinal muscular atrophy  Learn more about n-Lorem on their website.  Check out the UConn Podcast Symposium, our host Kira Dineen will be on the interdisciplinary panel taking place on February 22nd at 4PM EST. You can register to attend for free here. UConn students will be provided a Zoom link to engage in a live Q&A. The panel will also be streamed publicly via Facebook and YouTube. Stay tuned for the next new episode of DNA Today on March 5th, 2021! New episodes are released on the first and third Friday of the month. In the meantime, you can binge over 140 other episodes on Apple Podcasts, Spotify, streaming on the website, or any other podcast player by searching, “DNA Today”. Brand new in 2021, episodes are now also recorded with video which you can watch on our YouTube channel.   See what else we are up to on Twitter, Instagram, Facebook, YouTube and our website, DNApodcast.com. Questions/inquiries can be sent to info@DNApodcast.com.
Play
More episodes
Search
Clear search
Close search
Google apps
Main menu